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Abstract: Keratinocytes are activated to express MHC class II and ICAM-1 molecules durmg cutaneous
inflammatory reactions It IS controversial how the mteraction between these 'nonprofessional' antigen
presentmg cells (APC) and mfiltrating Τ cells affects the local inflammatory response To address this
lssue we analyzed whether IFN-y-treated cultured human keratinocytes would activate established Th
cell clones in vitro Three allo DR specific Τ cell clones were induced to prohferate in a HLA DR and
LFA-1/ICAM 1 dependent fashion upon coculture with mtact layers of IFN7 stimulated keratinocytes
Likewise, keratinocytes also could activate two out of four minor histocompatibility (mH) antigen
specific Th cell clones obtained from penpheral blood leukocytes (PBL) of graft veisus host disease
patients The Τ cell activating potential of MHC class 11+ keratinocytes was shown to be relatively low
compared lo speciahzed APC as PMNC and EBV BLCL Most stnkingly, measurable allo MHC and
mH antigen specific Th cell prohferation was only induced by using adherent keratinocytes at low cell
densiües, but not by keratinocytes in Suspension The resulls presented here indicate that in vitro
conditions may crucially influence observations regardmg the Τ cell activating potential of MHC class II
expressing keratinocytes Furthermore, our results mdicate that, in addition to a tolenzmg effect as
suggested by previous reports, mteraction of primed antigen specific Τ cells with activated keratinocytes
may also lesult in enhancement of a cutaneous immune response in vivo
Introduction
Epidermal keratiaocytes are activated to express class II
MHC and ICAM-1 molecules in a vanety of lymphocyte-
mediated skm diseases, such as graft versus host disease
(GvHD) after allogeneic bone marrow tiansplantation
(BMT)1 3 Activation of keratinocytes is thought to be in-
duced by IFN-γ and TNFa locally secreted by mfiltratmg
mononuclear cells4~6 The biological consequences of acti-
vated c)ass 11+ ICAM-1 + keratinocytes on a cutaneous
mfiammatory response are not fully understood In response
to IFN-γ, keratinocytes efficiently bind Τ lymphocytes via
mteraction of ICAM-1 with lts hgand LFA-1 4 7 Furthermore,
act.vated keratinocytes are rendered susceptible to lysis by
MHC class I and class II restncted CD8+ and CD4+
cytotoxic Τ cells in vitro* n and thus may s>erve as targets for
antigen-specific effector cells in mflamed skin With respect to
the events lmtiating cutaneous Τ cell inflammation, MHC
class 11+ keratinocytes are thoughl not to be mvolved in the
initial antigen-specific tnggenng of resting Τ cells 13~15 This
process appears to be stnctly mediated by the bone marrow-
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denved population of class 11+ epidermal Langerhans' cells
(LC) which are highly efficient m presentmg exogenous as
well as modified seif antigens to Τ cells n 1 6 By contrast,
activated keratinocytes are considered to be responsible for
persistence of inflammatory reactions via amplification of the
local Τ cell response 17~19 Keratinocytes are assumed to do so
via secretion of numerous Τ cell stimulatory lymphokines
mcludmg IL-1, IL-6 and IL-8 1 8 2 0 2 1 Α second mechamsm by
which keratinocytes might cause progression of ongoing
inflammation, would be to directly activate adhenng Τ cells
by tnggering their antigen-specific receptor To what extent
this second mechamsm could occur and which antigemc
epitopes are involved m the distinct inflammatory diseases is
as yet unclear In ex vivo modeis developed to define the role
of class 11+ keratinocytes in psonasis,22 tuberculm-
reactivity23 and GvHD,24 MHC 11+ keratinocytes isolated
from affected skm were unable to stimulate primed PPD or
allo MHC-specific Th cells Furthermore, controversial re-
sults were obtained in in vitro studies aiming to elucidate the
intrmsic potential of suspensions of cultured or uncultured
class 11+ keratinocytes to present allo MHC 8 2 5 hapten-
modified seif,26 exogenous8 or peptidic antigens8 2 5 to primed
Th cells Not only differences in Τ cell activation8 2 5 but also
mductton of antigen specific Τ cell unresponsiveness25 2 6 were
observed.
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In the present study an in vitro model employing intact
layers instead of suspensions of cultured IFN7 treated kerati-
nocytes was developed and used to assess the capacity of
MHC class II+human keratinocytes to activate allo major
and minor histocompatibüity (H) antigen specific Th cell
clones We report that under restncted in vitro conditions
adherent keratinocytes can mduce proliferation of pnmed
allo DR antigen specific Th cells Furthermore, preliminary
results are reported suggesting that allo mH antigen specific
Th cells detected in the blood of GvHD patients might be
susceptible to Stimulation by keratinocytes in GvHD-affected
skm
Objective
The objective of this study IS to address the controversial
l&sue of whether IFN7 activated epidermal keratinocytes
have the capacity to activate skin mfiltratmg pnmed allo-
antigen specific Th cells This, in order to gam insight mto the
contribution of epidermal cells to the cascade of mflamma-
tory events occurrmg in cutaneous allo-graft rejection, DTH,
and graft versus host reactions
Materials and methods
Τ cell clones and lines
The DR3 specific Th cell clone 1603, a DR2 specific Th clone
2610, a DRwll specific Τ cell hne RT222 and a DPw4 1
specific Th hne were all kmdly provided by Dr Α Termijtelen
mH antigen specific Th cell lmes were all estabhshed in our
laboratory from pnmed PBL of patients after HLA genotyp-
lcally identical BMT as previously described in detail27 The
CD4+ Th cell hnes DAx and FAx display DR5 respectively
DR3 + DR5 restncted recogmüon of as yet umdentified
autosomal mH antigens, each expressed on PBL and EBV-
LCL of the BM recipient and on PBL and EBV-BLCL of
some of a panel of restnction antigen positive unrelated
mdividuals Α CD8+ Th cell clone R26 and a CD4+ Th cell
clone R41628 recogmze the male specific mH antigen H-Y
presented by the MHC class I molecules HLA-B60 and -A2
respectively All Th cell hnes and clones were expanded by
adding PMNC of the original stimulator (107, 3000 rad) or
EBV-LCL of the original stimulator (2 Χ106, 5000 rad) and
autologous PMNC (107, 3000 rad) as feeder cells to 1 Χ 106 Τ
cells in 10 ml of medmm (RPMI1640 supplemented with 15%
human serum) with 20 U rll-2/ml At day 9-10 after restimula-
tion, the Τ cells were frozen and after thawmg directly using
as responder cells for proliferation
Human keratinocyte cultures
Keratinocytes (KC) were standardly isolated from skin biop-
sies of a selected panel of 9 HLA and mH antigen typed
donors Cells were cultured in culture flasks coated with
irradiated 3T3 feeder cells m culture medium (KM) com-
posed of a 3 1 mixture of DMEM and Ham's F12 (Gibco),
supplemented with 5% FCS, 10 6 Μ isoproterenol (Sigma),
0 4 μg/ml hydrocortisone and 10 ng/ml EGF (Sigma) as pre-
viously described9 KC cell suspensions to be used for pro-
liferation assays (direct or after adhesion) or FACS analysis
were obtamed by detachmg KC from subconfluent 3^ih
passage cultures using 0 25% trypsm (Difco) supplemented
with 0 05 Μ EDTA and 0 1% glucose (pH = 7 5)
Immunofluorescence analysis
Single cell suspensions obtamed via trypsmization of subcon-
fluent KC cultures were analyzed on a FACScan flow cyt-
ometer (Becton Dickmson, Palo Alto, CA) Cells were
mcubated with mAb, washed and stained with FITC-goat
anti-mouse IgG for measurement of mdirect fluorescence
Proliferation assays
In the conventional pnmed lymphocyte test (PLT) 1-2 Χ 104
Τ cells were cocultured with 105 PMNC (2000 rad), or
0 25 X105 EBV LCL (7500 rad), or KC (3000 rad, see below)
in a volume of 150 μΐ RPMI +15% HS in 96 wells flat-
bottomed plates (Greiner 655160) for 48 hours Tnphcate
cultures were labelled with 1 μ θ [3Η] thymidine and after 16
hours assayed for isotype incorporation in a liquid scintilation
counter Layers of KC lo be used as stimulator cells (SC),
were generated (unless stated otherwise) by adding a Suspen-
sion of 200 μΐ KM contammg 104 undifferentiated KC in 96
wells flat bottomed pldles, allowed to adhere for 24 hours,
followed by the addition of rIFN7 (Genentech, San
Francisco, CA) to a final concentration of 200 U/ml After six
days of IFN-γ incubation, subconfluent KC layers were
washed three times with 37°C PBS, irradiated 3000 rad and
cocultured with 1-2 Χ 104 Τ cells/w for 64 hours as described
above When KC in Suspension were used as SC, IFN7 was
added in the flasks to subconfluent cultures Single cell
suspensions generated by trypsmization were washed, irra-
diated 3000 rad and directly used as SC m PLT Where the
effect of mAb against cell surface molecules on antigen-
specific proliferation was studied, either responder Τ cells of
KC were preincubated in 100 μΐ of the mdicated mAb
dilution for 30 minutes at 20°C mAb were left m the culture
medium for the duration of the assay
Assay for Τ cell unresponsiveness
KC were plated out in 96 wells plates (10 000 and 40 000 KC/
w), allowed to adhere overmght and cultured for 72 hours in
the presence of IFN7 at 200 U/ml Generated subconfluent
(10 000) and confluent (40 000) KC layers were washed using
PBS (3X), irradiated 3000 rad and mcubated with 3 Χ 104 Τ
cells/w in 15% HS in RPMI for 24 or 48 hours Τ cells were
carefully removed, extensively washed and tested for induced
unresponsiveness in a conventional PLT assay
Monoclonal antibodies (mAb)
HLA-reactive mAb were W6/32 and B912 1 (anticlass I
framework), PvD5 2 (anticlass II framework), B8 11 2 (anti
HLA DR) and B7 21 (anli HLA-DP) The anti LFA-1 mAb
8 3 14 1 was produced in this laboratory ICAM 1 reactive
mAb were RR1/1 (kmdly provided by Dr Τ Springer) and
15 2 (kmdly provided by Dr Ν Hogg)
Results
IFN-v-treated keratinocytes induce proliferation
of allo DR specific Th cell clones
We set out to address the controversial lssue of whether
activated DR + ICAM + KC might serve to perpetuate on-
gomg Τ cell responses in mflamed skin m vivo To mimick
mflamed epidermis, an in vitro model was chosen which
utihzes mtact layers of IFN7-treated cultured KC instead of
cell suspensions In this culture System, which was mitially
developed to study cell mediated cytotoxicity of KC,9 Single
cell suspensions obtamed by trypsin treatment of subcon-
fluent KC cultures are seeded at 10 000 KC/weil in 96 flat-
bottom plates, allowed to adhere overmght and mcubated
with rIFN-γ at 200 U/ml for three days ' I n a first senes of
expenments, intact KC layers were generated from mne
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selected HLA-typed mdividuals, washed, irradiated (3000
rad) and used as stimulator cells (SC) for 3 allo DR and 1 allo
DP specific Th cell clones in a PLT assay Table 1 gives the
results of a representative expenment, where IFN7 treated
and untreated KC layers of four donors were cocultured for
64 hours with 104 RC/w of a DR3 specific Th cell clone (1603)
or a DR2 specific Th cell clone (2610) KC were observed to
induce sigmficant (4 2-25 7 Χ103 cpm) [3H] thymidme in
Corporation of DR2 and DR3 specific Th cells provided KC
expressed the nght DR allele and had been rIFN-γ pretreated
(Table 1) To determme which accessory molecules were
involved in the observed KC-mediated Τ cell prohferation,
expenments were performed in the presence of antibodies to
several cell surface antigens (Figure 1) Anti-DR (B 8 11 2)
and ctMHC class II (PvD5 2) mAbs almost completely pre
vented prohferation, in contrast to irrelevant mAbs specific
for MHC class I (W6/32) or HLA-DP (B7 21) which did not
sigmficantly mhibit prohferation The LFA 1/ICAM-l mter-
action was indicated to contnbute to allo DR specific pro
hferation, even though both aICAM-1 (RR1/1) and aLFA-1
(8 3 14 1) mAbs did not completely abrogate Τ cell activation
(Figure 1)
Table 1 IFN-y treated keraünocytes induce DR specific Τ cell
prohferation
Keraünocytes"
Donor HLADR
Prohferation (cpm χ 103)
1603 (<xDR3) 2610 (aDR2)
AT
EG
VD
DH
3
3,7
2,5
2,3
25 7b (0 4)c
16 8 (0 3)
0 6 (0 5)
10 9 (0 5)
0 6 (0 4)
0 6 (0 3)
7 0 (0 3)
4 2 (0 4)
aKC layers generated by seedmg and allowmg to adhere
10 000 K/w, followed by a 72 hour penod with 200 U/ml IFN-y were
used as SC after washing and 3000 rad irraddiation
bValues represent mean [3H] thymidine incorporation in 103 cpm
of tnphcate wells contaimng ΙΟ4 Τ cells and IFN7 treated KC in a 64
hours PLT assay
cValues between brackets stand for prohferation induced by IFN-y
untreated KC, background values of Τ cells or KC alone were always
below 0 5 Χ 103 cpm
Antibody
B8112
PvD5 2
40 60
% Inhibition
100
Figure 1 Effect of mAbs on KC induced prohferation of anti DR3 Th
cell clone 1603 KC layers, prepared as descnbed in Table 1, were
incubated for 30 minutes at 20°C in 100 μΐ of a 1 200 dilution of
W6/32 (anti MHC class I), PvD5 2 (anti class Π), Β8 11 2 (anti HLA
DR), B7 21 (anti HLA DP) and RR1/1 (anti ICAM-1) The anti
LFA 1 mAb 8 3 14 1 was preincubated with RC instead of SC Mean
values of [3H] thymidine incorporation of three expenments are
presented as percentages ±SD of the unblocked response (always
>10X!03cpm)
in vitro parameters influence Τ cell activation by
IFN7-treated keratinocytes
Effect ofICAM 1 and HLA-DR expression
IFN7 pretreatment of KC layers was vaned with respect to
time (zero to six days) and concentration (50-500 U/ml) to
determme optimal conditions for in vitro Τ cell activation
IFN7 was added at distinct time points to wells simultane
ously seeded with 10 000 KC/w As Table 2 indicates, concen-
trations exceeding 50 U/ml did not further enhance
KC-mduced Τ cell prohferation Prolonged IFN7 incubation
of KC for five or six days appeared to optimize the resulting
prohferative Τ cell response (Table 2) This result was unex-
pected since both ICAM-1 and HLA-DR expression are
known to be rapidly induced by IFN7 2 9 3 0 To confirm the
kmetics of IFN7-mduced ICAM 1 and HLA DR cell surface
expression in our KC culture System, FACS analysis was
performed with Single cell suspensions obtamed via trypsmi-
zation of KC cultures preincubated with 200 U/ml rlFN-/ for
zero, one, two, four and seven days Maximal densities of
HLA DR (B8 111) and ICAM 1 (RR1/1) were observed
after two and one day respectively (Figure 2) This rapid
mduction and the declming ICAM 1 expression after four
days (Figure 2B) mdicates that cell surface expression of
HLA-DR and ICAM-1 are not the only factors determining Τ
cell prohferation induced by IFN7 treated KC (Table 2) The
fact that IFN7 exerts a strong inhibitory effect on KC growth
(data not shown and 3 1 ), might contnbute to the findmg that
longer pretreated KC layers (contaimng less adherent KC)
induce higher values of Τ cell prohferation (see KC density)
Table 2 Effect of ΙΡΝγ pretreatment of keratinocytes on DR
specific Th cell prohferation
timC
(days)
(U/ml)
50 100 200 500
2
3
4
5
6
0 3"
0 1
0 4
0 3
0 2
6 0
14 9
14 8
22 3
20 0
6 3
16 2
18 3
22 3
24 9
6 2
14 9
18 5
27 6
27 2
6 5
13 0
154
22 5
23 0
aKeratinocytes of a DR3+ donor were seeded at 104 cells/well
seven days before usage as SC layers in a PLT assay IFN7 was added
at the mdicated concentraüons on consecutive days starting 12 hours
after KC seeding corresponding to six days IFN-y
bMean [3H]thymidine incorporation (cpm X10 3) of tnphcate
wells contaimng 104 <xDR3 Τ cells in a 64 hours PLT assay Results of
one of two expenments are shown
Effect of KC density
To determme the effect of KC density, cell suspensions of
four DR3+ KC lmes ranging from 5-400 X103 KC/ml ( le
1-80 Χ103 KC/well) were seeded in 96 wells plates, allowed to
adhere overnight, incubated with 200 U/ml IFN7 for six days
and used as SC in PLT Prohferation mduction of the aDR3 Τ
cell clone strongly vaned (2-11 Χ 103 cpm) with the number of
seeded KC/w, with an optimal Stimulation at 5-10 Χ103 KC/
well (Figure 3) Α Standard protocol for most sensitive
(withm our test ranges) measurement of Τ cell prohferation
mduction by KC was used in all fulure expenments and
consisled of (washed and 3000 rad irradiated) subconfluent
KC layers generated by seedmg 5000 as well as 10 000 KC/w,
followed by a six-day incubation penod with 200 U/ml
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JW6/32 RR1/1 B8.11.2
Log Fluorescence Intensity
Figure 2 Cell surface expression of HLA class I (A), ICAM 1 (B) HLA DR (C) of cell suspensions of trypsimzed keratinocyte cultures after
incubation for zero (—), one (-—), two (—), four (—) and seven ( ) days with 200 U/ml 1IFN7
[3H]TdR mcorporation (cpmxid )
12
10
o' —
500
Keratinocyte culture supernatants inhibit Τ cell
proliferation in allo MLR
The reduced allo DR Τ cell proliferation at high KC cell
densities could be caused by Τ cell mhibitory factors secreted
by KC RPMI media conditioned for 24-72 hours on subcon-
fluent layers of KC, were removed and compared with
unconditioned medium for lts abihty to inhibit a pnmary allo
MLR As shown in Table 3, the degree of Inhibition of the
MLR was dependent on the penod the RPMI medium had
been conditioned by KC Inhibition (up to 65% of control)
was observed irrespective of whether KC had been IFN7
pretreated, irradiated or whether indomethacin had been
added to the RPMI
5000
# Κ seeded/well (log)
50000
Figure 3 High as well as low densities of adherent KC/well are
suboptimal for in vitro activation of allo reactive pnmed Th cells
Mean values of [3H]-thyrmdine incorporation by anti DR3 Th cells
measured after coculture with four DR3+ KC cell lines in two
expenments are given IFN7 pretreatment consisted of 6 d,
200 U/ml
Table 3 KC culture supernatants mhibit Τ cell proliferation in allo MLR
The Th cell activating potential of HLA-DR+
ICAM-1 + keratinocyte layers is low compared to
that of 'professional' APC
To address the relative antigen presentmg potential of KC,
values of Τ cell proliferation induced by intact layers of IFN7-
treated KC, suspensions of trypsimzed IFN7 pretreated KC,
IFN7, 3 d
200 U/ml
-
+
-
+
+
KC pretreatmenf
3000 rad
Irradiation
+
+
—
+
Indomethacin
1 u-g/ml
-
—
—
—
+
Conditiomngb
penod (hours)
—
24
48
72
24
48
72
24
48
72
24
48
72
Prohferationc
(cpm Χ 103)
25 3 + 2 2
15 7 + 12
106 + 02
9 0 ± 1 3
13 6 ± 0 3
112 + 07
127 + 24
13 8 + 1 8
90-t l 1
92 + 12
191 + 23
12 2 + 1 7
10 9 + 3 0
•"Followmg IFN7 pretreatment and/or Irradiation as mdicated, subconfluent KC layers were incubated in RPMI + 15% HS in the piesence of
absence of indomethacin
bSamples of RPMI preconditioned by ±4 χ 104 KC per 0 2 ml RPMI were drawn after the mdicated penod, filtered, adjusted to pH - 7 0-7 2
and added to MLR
cMean pHJthymidine incorporation of tnplicate wells of two expenments, in which 105 PMNC were cocultured with 1(Γ" 2000 lad allogeneic
PMNC foi five days in a volume of 3 50 μΐ conditioned RPMI
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[3H]TdR incorporation (cpm χ 10" )
60 ι
- · - DR· Κ layer
- ^ - DR+ Κ suspended
- * - EBV-BLCL
• PMNO
100 1000
log stimulator cells (x10 )
Figure 4 Comparison of the Τ cell activating potential of keratino-
cytes and specialized APC. ceDR3 Τ cells were stimulated with
varying numbers of PMNC (B,6-50 Χ103, 2000 rad), EBV-BLCL
(*,2-50 x 103,7500 rad), and trypsinized and suspended 6 d 200 U/ml
ERSfy-treated KC ( •, 0.8-100 Χ 103, 3000 rad) in a conventional PLT.
Also layers of KC generated by seeding 1,2-200 Χ 103 K/well, incu-
bated with 200 U/ml rIFN7 for six dyas, were used as SC (·,3000
rad). All cell types were obtained from the same HLA-DR3+
donor.
EBV-BLCL and PMNC were compared as SC in PLT. Figure
4 represents one of two experiments where distinct cell types
of the same DR3+ donor were used as SC for an aDR3 Th
cell clone. Τ cell activation induced by DR+ KC layers was
significant (=sl3 X 103cpm) but lower than Τ cell activation
induced by PMNC (=£60 Χ103 cpm), or EBV-BLCL
(«47X103 cpm), even at optimal KC densities. Surprising
results were obtained using Single cell suspensions obtained
via trypsin detachment of IFN^-treated KC cultures. Irra-
diated (Figure 4) as well as unirradiated (not shown) suspen-
sions of the same DR3 + KC line did not result in significant
[3H]-thymidine incorporation (3=1 Χ 103 cpm) by aDR3 Τ
cells in the concentration ränge tested (0.8-100 Χ 103 KC/w).
Similarly, proliferation by aDR2 and «DR5 Th cell clones
never exceeded 0.5 Χ 103 cpm when cocultured with antigen-
positive suspensions of KC (data not shown).
IFN-y-stiinulated keratinocyte layers activate MHC
restricted Th cell clones specific for H-Y, but not Th
cell clones specific for two other mH antigens
In a previous study we found that the presence of host mH
antigen reactive proliferative rather than cytotoxic Τ cells in
blood of patients after HLA-identical BMT was correlated to
the development of graft versus host disease.27 In GvHD, mH
antigen reactive Th cells might be locally activated by antigen
expressing keratinocytes in the GvHD affected skin.32·33 As
indicated in Figure 5, IFN7 pretreated keratinocytes of a male
HLA-B60+ donor were able to induce proliferation of the
H-Y/B60 CD8+ Τ cell clone R26, whereas IFN-y-treated
female or B60-negative or IFN7 untreated cells could not
(Figure 5A). Similarly, the H-Y/A2 specific CD4+ Τ cell
clone R416 was only stimulated by IFNy-treated male HLA-
A2+ keratinocytes (Figure 5b). The failure of IFN7 un-
treated KC, which do express MHC class I (Figure 2), to
activate R416 and R26 is compatible with our previous
results.10 CTLs specific for H-Y in the context of MHC class I
only lysed KC after IFN-y treatment.10 Activation presumably
results only after an increase in the number of MHC class
I/H-Y complexes and facilitated adhesion via ICAM-1 as a
result of IFN7 treatment. Values of [3H] thymidine incorpora-
tion by both male specific Τ cell clones were low (4.9 ± 0.5 and
5.8 ± 0.3 Χ 103 cpm respectively), but reproducable and repre-
sented 27% and 24% of the responses of these clones induced
by PMNC. The MHC class I restriction of KC-induced
proliferation of ctH-Y/A2 Th cells was confirmed by antibody
pH]TdR incorporation (cpm χ 10 - 3 \
Käää 1150
t'ZJ 1 1600
CZI 1 15000
B9 12.1 B8 112
antibody
_i _
B7.21 8 314.1 15.2
Figure 6 Effect of anti HLA class Ι (Β9.12.1), DR (B8.11.2), DP
(B7.21), and anti (LFA-1 (8.3.14.1) and ICAM-1 (15.2) mAbs on KC
induced proliferation of H-Y/A2 specific Th clone R416. KC layers
(10.000 kC/w; 6 d, 200 U/ml rIFN7) of a HLA-A2+ male donor were
used as SC in PLT.
SEX HLA
Α: H-Y/ B60 Β: H-Y/ A2 C: mH/ DR5 D: mH/ DR5
Μ
Μ 1,11 8,60 2,3
1,2 8,15
0 20
incorporation (cpm χ 10 )
6 0
Figure 5 Keratinocytes induce activation of some mH antigen-specific, MHC-restricted Τ cell clones. Of three HLA typed individuals PMNC and
IFN7 untreated and treated layers of KC, as well as suspensions of IFN7 treated KC were used to induce proliferation of an H-Y specific, HLA-
B60 restricted Th cell clone R26 (A); an H-Y specific HLA-A2 restricted Th cell clone R416 (B); a DR3+ 5 restricted Τ cell line FAx (C); and a
DR5 restricted Th cell line DAx (D) both reactive with nonsex linked unidentified mH antigens. Background values of RC and SC alone were
always below 300 cpm.
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Inhibition expenments, which revealed a dose-dendent Inhibi-
tion by cdCAM-1, aLFA-1 (partial) and aMHC class I mAbs,
but not by aMHC class II mAbs (Figure 6) In contrast, IFlSty
treated keratinocytes of two HLA-DR5+ donors did not
mduce any measurable proliferation of the DR3/5 restncted
mH antigen specific Τ cell lme FAx («0 3 Χ 103 cpm, Figure
5C), or similarly, of the mH epitope reacüve, DR5 restncted
lme DAx (Figure 5D) As expected, suspensions of IFN7
treated KC (10 and 40 Χ103 KC/w) did not stimulate any of
the four Th cell clones at all
Absence of mH specific proliferation is not due
to KC-induced Τ cell anergy
The faüure of the two mH antigen specific Th cell lmes FAx
and DAx to be activated by KC can be explamed in three
ways First, the MHC class II restncted, mH antigen specific
Th cells tested may have activation requirements different
from the allo DR and H-Y specific Th cells tested Secondly,
keratinocytes may not express the two DR restncted mH
epitopes on their cell surface Thirdly, DAx and FAx Th cells
may have been rendered anergic as a result of coculture with
IFN-γ KC The latter possibility was expenmentally addressed
in Figure 7 DAx (Figure 7) or FAx (not shown) Τ cells were
premcubated for 24 hours or 48 hours in either medium alone,
or on top of KC layers of a mH antigen positive donor (IFN7
treated or not), or of a mH antigen negative donor No
difference m the prohferative responses was observed when
these differently premcubated Τ cells (after extensive wash-
mg) were subsequently stimulated with adequate mH antigen
positive APC in a conventional PLT assay (Figure 7) Thus,
the absence of measurable proliferation of the mH specific Τ
cell lme DAx after coculture with IFN-y-treated KC layers
potentially expressing the mH antigen, is not due to KC-
induced unresponsiveness of these Th cells
Discussion
It is estabhshed that activated epidermal KC, even though
secreting several lymphokines mcluding IL-1 and expressing
cell surface MHC class II and ICAM-1, are unable to mduce
pnmary Τ cell activation.81415 2 4 2 9 In the course of an ongoing
mflammatory reaction, KC may encounter nonvirgm Τ cells
which have previously been activated by bone marrow-
denved 'professional' antigen presentmg cells (APC) such as
dendntic (Langerhans') cells Given that memory Τ cells are
less strmgent in the activation Signals they require,3435 the
question was asked by several mvestigators whether MHC
class 11+ KC, hke several other MHC class 11+ non bone
marrow-denved cell types,36 3 7 might be sufficient to stimulate
established Th cell populations Thus far, controversial results
have been reported on the capacity of suspensions of IFN-y-
treated KC to mduce proliferation of allo MHC class II
reactive Th cell populations Gaspan et al reported on an
aIAk Τ cell lme, which could be induced to prohferate in an
MHC class II dependent fashion by coculture with MHC class
11+ KC punfied from skm of in vivo IFN-y-treated mice8
Seemingly contrastmg data are presented in this report
(Figure 4) and in a previous report by Bai et al25 showmg that
human MHC class 11+ KC, obtained by trypsin-detachment
of IFN7 pretreated cultures, were totally unable to stimulate
cell drvision of allo HLA-DR Th cell clones Several factors
may account for this difference First, the species difference,
though this seems a trivial explanation Secondly, fresh
preincubation of DAx Τ cells
15 % HS in RPMI
IFNy+ Κ (10.000/w) of a DR5+ mH+ donor
IFNy+ Κ (40.000/w) of a DR5+ mH+ donor
IFNy- Κ (10.000/w) of a DR5+ mH+ donor
IFNy+ Κ (10.000/w) of a DR5+ mH- donor
SC-DR5+ mH+ PBL
SC-DR5+ mH- PBL
0 50 100 150 200
THlTdR incorporation (cpmxiö3)
Figure 7 Absence of proliferation by the mH specific, DR5 restncted Th cell hne DAx is not due to anergy 3 x 104 DAx Τ cells/w were
premcubated for 24 hours at the mdicated conditions Harvested Τ cells were tested for induced anergy m a conventional PLT using DR5+ mH+
and DR5+ mH- PMNC as SC
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uncultured KC remain viable for a longer penod when
suspended in Τ cell culture medium than cultured KC 2 9
Likewise, termmal differentiation of detached KC (see be-
low) may have distinct kinetics for purified versus cultured
KC Thirdly, since KC were found to be mefficient APC
compared to spieen cells,8 they may only mduce measurable
activation of those Th cell clones with a very high pro-
liferative potential
The potential role of in vitro KC treatment on allo MHC
Th cell activation is most stnkingly lllustrated by the data
shown here Whereas suspensions of class 11+ KC, generated
by trypsm-detachment of IFN7 treated cultures, were unable
to mduce allo DR specific Τ cell prohferation (Figure 4),
intact layers of IFN7 treated KC at the nght density activated
these Τ cells in an ICAM 1 and HLA-DR dependent fashion
(Table 1, Figure 1) Since most mvestigators thus far used
suspensions of KC as stimulator cells, lt is relevant to
understand the apparent differential Τ cell activating capacity
of suspended versus adherent KC First, the exposure of KC
to trypsm is thought to mduce ngorous membrane changes38
and has been suggested by some authors to affect the ICAM-
1 molecule 3 9 4 0 FACS data of trypsm treated KC cell suspen
sions (Figure 2)3Ü argue agamst trypsm sensitivity of the
RR1/1 antibody binding Site on ICAM 1 However, this does
not exclude that the epitopes for LFA 1 bindmg to ICAM-1
might still be affected by trypsm treatment In contrast to
when directly used as suspended SC, these potentially trypsm
affected KC may, after the subsequent culture penod (three
to six days), express newly synthesized ICAM-1 molecules
when used as intact layers Secondly, cultured KC, when
detached from their Substrate, rapidly undergo the destruc
tive process of termmal differentiation 4142 Within the first 12
hours in Suspension RNA and protem synthesis have virtually
stopped and keratin filaments of the extracellular matrix
become cross linked These dying KC might fall to provide
pivotal costimulatory Signals which viable adherent KC do
provide In addition, the changes m the extracellular matrix
may negatively affect Τ cell binding to KC Whichever the
exact mechamsm causing the severely reduced Τ cell activat
ing potential of suspended KC, intact layers of basal KC most
probably represent a more adequate in vitro model to study
KC-mediated Τ cell activation in vivo
We observed a stnking Variation of prohferation of anti
DR Th clones with degree of confluence of the KC layers An
mcrease in KC plated per well from the optimal number of
5X104 to 100 XlO4 fully abrogated prohferation (Figure 4)
Since KC-conditioned medium was found to inhibit Τ cell
prohferation in an allo MLR (Table 3), the presence of Τ cell
inhibitory factors in the assay medium is mdicated to account
for the observed dose-dependent reduction of Τ cell pro-
hferation Additional expenments are required to identify
these factors Previous reports have suggested that PGE2 and
TGFß might be mvolved 2943
The data discussed thus far have mdicated the relevance of
the in vitro treatment of the KC cell population used as SC
However, the controversial data on Τ cell activation by MHC
class 11+ KC cannot be solely attnbuted to expenmental
differences, since diversity in Τ cell activation has been
observed within one Single KC model Gaspan reported that
KC activated an allo IAk Τ cell (8 see above), but not a TNP-
specific IEk restricted Τ cell clone 2(S Instead, overmght co
culture with antigen expressmg KC rendered the latter Τ cell
clone anergic, as marked by long-term unresponsiveness to
subsequent tnggenng by adequate APC Α similar observa
tion of tolerance induction instead of activation was reported
by Bai, mvolvmg a DR restricted Influenza hemagglutinm
peptide specific Th cell clone after coculture with peptide and
IFN7 pretreated layers of human KC 2 5 Although the nature
of the Signals leading to Τ cell anergy IS not yet fully clear, lt is
estabhshed that occupancy of the TCR by antigen in the
absence of additional positive Signals in vitro can mduce this
Τ cell State34 Antigen positive MHC class 11+ KC appear to
anergize some and to activate other Th cell populations
Differences between responder Τ cells in terms of (1) activa-
tion requirements and (2) antigemc specificity might account
for this phenomenon lt is well estabhshed that munne Th cell
clones belongmg to the Thl subset have distinct requirements
than Th2 cell clones35 and that Thl cells can be anergized
under certain in vitro conditions 3 4 4 4 The allo MHC and mH
antigen specific Th cell clones activated by KC (Table 1,
Figure 5) have yet to be categonzed as Thl or Th2-hke Both
Th cell clones which were rendered anergic after coculture
with antigen- and MHC class II-expressing KC were of the
Thl or (in human) of the Thl-hke subset2 5 2 6 In contrast,
recent data by our group mdicate that Th cells of the Thl-hke
subset can very well be activated by KC 1 2 The second aspect
potentially lnfluencmg Τ cell activation versus mactivation is
the antigen specificity of the TCR Evidently, cell surface
expression of the antigemc epitope is a prerequisite to induce
an antigen specific (either positive or negative) response in Τ
cells Epitopes of soluble exogenous proteins which require
processmg,8 but also mH epitopes, may not be presented by
KC In previous reports we showed that the male specific mH
antigen H-Y is expressed by activated KC,10 in contrast to
some autosomal mH peptides n The observation that KC of
MHC-restnction and mH antigen positive donors failed to
induce either prohferation or anergy in two mH antigen
specific Th cells, is suggestive for the absence of these mH
antigens on KC to provide a Signal via the TCR However, the
antigen specificity of the Th cell clones studied cannot easily
explam the controversial results in Τ cell activation observed
in the presence of antigen Whereas the Th cell clones
rendered anergic were specific for TNP-modified IE k 2 6 and an
HLA-DR restricted viral peptide,25 those activated recog-
mzed allo DR8 (Table 1) or a seif class I restricted H-Y
peptide (Figure 5), but also HLA-DR restricted HSP-65
peptides 12
Evidently, a systematic analysis of a large panel of Th cell
clones with well defined antigen specificities and known Thl/
Th2 lymphokme production profiles is required within one in
vitro KC model to settle the question of what determmes if
KC activates or inactivate Th cells Still, the data presented
here serve to mdicate that coculture of KC with allo MHC J
and mH antigen specific Th cell clones can result in antigen
specific Τ cell Stimulation instead of mactivation lt is conceiv
able that in vivo Τ cell-KC mteractions can lead to either
outcome, depending on multiple factors mcluding antigen
specificity, activation requirement of the Τ cells involved, but
also local concentrations of antigen and lymphokmes
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